FDA Approves PDUFA Fee Waiver for Gimoti™ New Drug Application Read more about FDA Approves PDUFA Fee Waiver for Gimoti™ New Drug Application
Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2017 Financial Results Read more about Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2017 Financial Results
Evoke Announces Discovery of Sex-Based Pharmacokinetic Differences for Gimoti™ Read more about Evoke Announces Discovery of Sex-Based Pharmacokinetic Differences for Gimoti™
Evoke Pharma Reports Third Quarter 2017 Results and Highlights Read more about Evoke Pharma Reports Third Quarter 2017 Results and Highlights
Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific Read more about Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific
Evoke Pharma Schedules Conference Call and Webcast for Third Quarter 2017 Financial Results Read more about Evoke Pharma Schedules Conference Call and Webcast for Third Quarter 2017 Financial Results
Evoke Pharma Announces Conference Call to Review the Successful Results of Comparative Exposure Pharmacokinetic Study for Gimoti™ Read more about Evoke Pharma Announces Conference Call to Review the Successful Results of Comparative Exposure Pharmacokinetic Study for Gimoti™
Evoke Pharma Announces Positive Topline Results from Comparative Exposure Pharmacokinetic Study for Gimoti™ Read more about Evoke Pharma Announces Positive Topline Results from Comparative Exposure Pharmacokinetic Study for Gimoti™
Evoke Pharma to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference Read more about Evoke Pharma to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference
Evoke Pharma Completes Dosing for Gimoti™ Comparative Exposure Pharmacokinetic Study Read more about Evoke Pharma Completes Dosing for Gimoti™ Comparative Exposure Pharmacokinetic Study